Editorial Board and editorial team of Safety and Risk of Pharmacotherapy have selected and recommended 12 articles published in 2025 for a further promotion in terms of relevance, academic novelty, practical and clinical importance, interdisciplinary approach, and popularity.

1. Asetskaya I.L., Zyryanov S.K., Samsonova K.I., Butranova O.I., Terekhina E.N., Polivanov V.A. Medication Errors Associated with the Use of Levofloxacin: An Analysis of the National Database of Spontaneous Reports. Safety and Risk of Pharmacotherapy. 2025;13(1):44–57 (In Russ.). https://doi.org/10.30895/2312-7821-2024-444
2. Mazerkina I.A. Anti-amyloid Monoclonal Antibodies for Alzheimer’s Disease: A New Hope? (Review). Safety and Risk of Pharmacotherapy. 2025;13(1):7–19 (In Russ.). https://doi.org/10.30895/2312-7821-2025-13-1-7-19
3. Engalycheva G.N., Syubaev R.D. Relevant Species Selection for Preclinical Safety Studies of Medicines: A Review. Safety and Risk of Pharmacotherapy. 2025;13(1):31–43 (In Russ.). https://doi.org/10.30895/2312-7821-2025-460
4. Postnikov S.S., Teplova N.V., Gulbekova O.V. Thrombocytopenia as a Side Effect of Heparin Therapy and COVID-19 Vaccination: A Review. Safety and Risk of Pharmacotherapy. 2025;13(2):149–160 (In Russ.). https://doi.org/10.30895/2312-7821-2025-13-2-149-160
5. Bukatina T.M. Risk Assessment Algorithms in Pharmacovigilance: A Review. Safety and Risk of Pharmacotherapy. 2025;13(2):138–148 (In Russ.). https://doi.org/10.30895/2312-7821-2025-13-2-138-148
6. Gaiderova L.A., Alpatova N.A., Golovinskaya O.V., Guskov A.M., Lipatova E.K., Lavrova M.N. Implementation of the 3Rs Concept in Quality Control of Biologicals: Status and Prospects (Review). Safety and Risk of Pharmacotherapy. 2025;13(2):229–239 (In Russ.). https://doi.org/10.30895/2312-7821-2025-13-2-229-240
7. Sultanova K.T., Miroshnikov M.V., Borodina A.Yu., Simonova E.V., Ustenko Zh.Yu., Mazukina E.V., Kryshen K.L., Matichin A.A., Makarova M.N., Makarov V.G. Cardiovascular Safety Assessment of Medicines in Preclinical In vivo Studies: A Review. Safety and Risk of Pharmacotherapy. 2025;13(3):263–278 (In Russ.). https://doi.org/10.30895/2312-7821-2025-475
8. Fitilev S.B., Shkrebneva I.I., Klyuev D.A., Vozzhaev A.V., Ovaeva A.O. Safety of Post-Infarction Dual Antiplatelet Therapy and Patient Adherence: EMIAS Data Analysis. Safety and Risk of Pharmacotherapy. 2025;13(3):300–312 (In Russ.). https://doi.org/10.30895/2312-7821-2025-13-3-300-312
9. Koval V.R., Butranova O.I., Konstantinova T.G., Al-Mayahi A. Drug Allergy in Adults at a Multidisciplinary Hospital: Prevalence Assessment Using the Global Trigger Tool. Safety and Risk of Pharmacotherapy. 2025;13(3):313–323 (In Russ.). https://doi.org/10.30895/2312-7821-2025-481
10. Kirova A.G., Bellevich Yu.S., Sosin D.N., Mosolov S.N., Sychev D.A. Pharmacogenetic Biomarkers of Clozapine-Induced Sialorrhoea: A Systematic Review. Safety and Risk of Pharmacotherapy. 2025;13(4):382-393 (In Russ.). https://doi.org/10.30895/2312-7821-2025-517
11. Naumenko L.V., Govorova Yu.A., Таrаn A.S. Preclinical Ophthalmotoxicity Studies of Medicinal Products: a Review of Regulatory Approaches and Research Methods. Safety and Risk of Pharmacotherapy. 2025;13(4):411–425 (In Russ.). https://doi.org/10.30895/2312-7821-2025-406
12. Gomon Yu.M., Lavrova V.A., Kolbin A.S., Gorelov K.V., Neznanov N.G., Sultanova F.M. Safety of Antidepressants: Analysis of the Russian Database of Spontaneous Reports. Safety and Risk of Pharmacotherapy. 2025;13(4):370–381 (In Russ.). https://doi.org/10.30895/2312-7821-2025-521